Are you really worth a CHF 15 million salary, Mr. Schwan?

We take one day at a time. There is no money; we have to do something with constant learning. Our portfolio includes big splash in the industry. The product pipeline is like Picasso. Expertise decides the short time we have. Cruise for multiple sclerosis and DCF model million US dollars. This is the most successful launch in the history of Roche. Months ago a sensation. Significant contribution from the young, compensating and micro to the fans. Medicine and materials at the same time, strong growth. Important questions about environment, culture, and success. Marketing team views the studio Washington. The state becomes motor talk services from stakeholders. Privilege to be a shareholder. Long-term capital, celebration if something went wrong, forcing failing. Look at dynamics of researchers in Basel and San Francisco. Style is different but intrinsic motivation and resilience are key. In Europe, Switzerland has quiet passion. Experiment over and over again. Difference between US and Europe: US has venture capital investment, good ideas in Silicon Valley, Boston; Europe startups to date compared. Roche collaborates with academic and private institutions, acquires companies. Digital station will fundamentally change our business model for research, clinical development, commercial. Access to data and diagnostics. Only four percent of data is available in real world. We need advanced analytics and data access. Digital age of healthcare data is fragmented, especially in Switzerland's federalist system. Things are coming: revolution in genomics, big data, analytics. Personnel must learn machine intelligence. Evolution in Germany. The film of animation shows complexity of reality. Leadership duo.